(Q44200453)

30 November 2017

title

Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer (English)

1 reference

positron emission tomography

30 November 2017

main subject

1 reference

Adriaan A Lammertsma

8

0 references

author name string

Jacobus J M van der Hoeven

1

1 reference

30 November 2017

Otto S Hoekstra

2

1 reference

30 November 2017

Emile F I Comans

3

1 reference

30 November 2017

Rik Pijpers

4

1 reference

30 November 2017

Robert P A Boom

5

1 reference

30 November 2017

Dick van Geldere

6

1 reference

30 November 2017

Sybren Meijer

7

1 reference

30 November 2017

Gerrit J J Teule

9

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

236

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

619-624

1 reference

Re: Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management

30 November 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1422620

FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1422620

Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1422620

Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1422620

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1422620

[Summary of the guideline 'Sentinel node biopsy in breast cancer.' Dutch Work Group 'Sentinel Node Biopsy for Breast Cancer'].

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1422620

Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1422620

Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1422620

Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1422620

Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability

27 August 2018

1 reference

12 December 2020

Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis

1 reference

12 December 2020

Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies

1 reference

12 December 2020

Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations

1 reference

12 December 2020

Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer

1 reference

12 December 2020

Comparison of Attenuation-corrected and Non-corrected FDG-PET Images for Axillary Nodal Staging in Newly Diagnosed Breast Cancer

1 reference

12 December 2020

Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET

1 reference

12 December 2020

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose

1 reference

12 December 2020

Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma

1 reference

12 December 2020

The sentinel node in breast cancer: implications for adjuvant treatment?

1 reference

12 December 2020

Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry

1 reference

12 December 2020

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer

1 reference

12 December 2020

10.1097/00000658-200211000-00012

Identifiers

DOI

1 reference

30 November 2017

0 references

1 reference